KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,798 | -11.4% | 1,952 | -17.2% | 0.00% | – |
| Q2 2023 | $21,213 | +14.5% | 2,357 | 0.0% | 0.00% | – |
| Q1 2023 | $18,526 | +16.3% | 2,357 | 0.0% | 0.00% | – |
| Q4 2022 | $15,933 | -53.1% | 2,357 | 0.0% | 0.00% | – |
| Q3 2022 | $34,000 | +70.0% | 2,357 | +14.8% | 0.00% | – |
| Q2 2022 | $20,000 | -50.0% | 2,053 | -26.0% | 0.00% | – |
| Q1 2022 | $40,000 | +8.1% | 2,773 | 0.0% | 0.00% | – |
| Q4 2021 | $37,000 | -11.9% | 2,773 | +13.1% | 0.00% | – |
| Q3 2021 | $42,000 | -28.8% | 2,452 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | +37.2% | 2,452 | +47.2% | 0.00% | – |
| Q1 2021 | $43,000 | +72.0% | 1,666 | +26.4% | 0.00% | – |
| Q4 2020 | $25,000 | +47.1% | 1,318 | 0.0% | 0.00% | – |
| Q3 2020 | $17,000 | -19.0% | 1,318 | -24.1% | 0.00% | – |
| Q2 2020 | $21,000 | +31.2% | 1,736 | -17.3% | 0.00% | – |
| Q1 2020 | $16,000 | -60.0% | 2,099 | -13.3% | 0.00% | – |
| Q4 2019 | $40,000 | +73.9% | 2,422 | +24.6% | 0.00% | – |
| Q3 2019 | $23,000 | -46.5% | 1,944 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | – | 1,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |